The gene expression levels of cGAS, STING and the plasma levels of the cytokines IFN-α, TNF-α and IL-6 in patients with acute COVID-19 were evaluated according to factors considered risk factors for the severity of the disease, namely, sex, age and comorbidities. This evidence concerns the gene STING1 and COVID-19.